Abiopharma

🔍 CHIDSEY JOHN (Executive)

Company: HCA Healthcare, Inc. (HCA)

Report Date: 2026-04-28

Detailed Transactions and Holdings:

• Acquired 809 shares of Common Stock (Direct)
  Date: 2026-04-28 | Code: A | equity_swap_involved: false | shares_owned_after: 1,305.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-28 | Code: H | nature_of_ownership: By managed account | shares_owned_after: 3.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-28 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 25.00 | Footnotes: F2

Footnotes:

• F1: Represents common stock underlying 509 restricted share units attributable to an annual director equity award and 300 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2027 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date.
• F2: The shares reported herein are held in a fully managed account over which the Reporting Person does not have any investment authority. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein.